Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -784.16% is 577% below its 5-year average of -115.89%, near the low end of its 5-year range (-784.16%–-32.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 88.49% below its 12-month average of -416.02%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -784.16%.
RETURN ON INVESTED CAPITAL (ROIC)
-784.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-416.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-152.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-115.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-76.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-88.49%
CURRENT VS 3Y AVG
-414.84%
CURRENT VS 5Y AVG
-576.62%
CURRENT VS 10Y AVG
-924.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-2098.99%
vs the sector median at left
Tempest Therapeutics, Inc.
Market Cap
$12.58M
Return on Invested Capital (ROIC)
-784.16%
TTM Avg
-416.02%
3Y Avg
-152.31%
5Y Avg
-115.89%
Market Cap
$12.48M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-154.20%
3Y Avg
-205.70%
5Y Avg
-169.89%
Market Cap
$12.44M
Return on Invested Capital (ROIC)
-43.31%
TTM Avg
-42.56%
3Y Avg
-55.36%
5Y Avg
-44.03%
Market Cap
$12.78M
Return on Invested Capital (ROIC)
-86.22%
TTM Avg
-227.24%
3Y Avg
-220.51%
5Y Avg
-220.51%
Market Cap
$12.17M
Return on Invested Capital (ROIC)
-358.04%
TTM Avg
-62.86%
3Y Avg
-6481.16%
5Y Avg
-4328.67%
Market Cap
$12.06M
Return on Invested Capital (ROIC)
-74.94%
TTM Avg
-273.26%
3Y Avg
-277.38%
5Y Avg
-186.51%
Market Cap
$13.11M
Return on Invested Capital (ROIC)
-889.92%
TTM Avg
-97.42%
3Y Avg
-82.73%
5Y Avg
-70.79%
Market Cap
$13.20M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-48.11%
3Y Avg
-41.05%
5Y Avg
-37.60%
Market Cap
$11.93M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. (TPST) | $12.58M | -784.16% | -416.02% | -152.31% | -115.89% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -203.50% | -154.20% | -205.70% | -169.89% |
| Cytosorbents Corporation (CTSO)vs › | $12.44M | -43.31% | -42.56% | -55.36% | -44.03% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -86.22% | -227.24% | -220.51% | -220.51% |
| Lantern Pharma Inc. (LTRN)vs › | $12.17M | -358.04% | -62.86% | -6481.16% | -4328.67% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.06M | -74.94% | -273.26% | -277.38% | -186.51% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -889.92% | -97.42% | -82.73% | -70.79% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -67.62% | -48.11% | -41.05% | -37.60% |
| Biofrontera Inc. (BFRI)vs › | $11.93M | -32.27% | -112.80% | -113.13% | -94.20% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -28.72% | -40.11% | -38.90% | -32.17% |
ROIC
-784.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -784.16% |
| 2026-03-31 | -583.02% |
| 2025-12-31 | -195.17% |
| 2025-09-30 | -267.69% |
| 2025-06-30 | -250.08% |
| 2025-03-31 | -194.10% |
| 2024-12-31 | -124.99% |
| 2024-09-30 | -125.57% |
| 2024-06-30 | -87.33% |
| 2024-03-31 | -73.61% |
| 2023-12-31 | -62.73% |
| 2023-09-30 | -163.52% |
| 2023-06-30 | -130.62% |
| 2023-03-31 | -108.82% |
| 2022-12-31 | -89.25% |
| 2022-09-30 | -77.55% |
| 2022-06-30 | -62.85% |
| 2022-03-31 | -65.07% |
| 2021-12-31 | -50.71% |
| 2021-09-30 | -39.34% |
| 2021-06-30 | -32.98% |
| 2021-03-31 | -71.64% |
| 2020-12-31 | -98.25% |
| 2020-09-30 | -64.91% |
| 2020-06-30 | -70.46% |
| 2020-03-31 | -66.70% |
| 2019-12-31 | -70.49% |
| 2019-09-30 | -83.37% |
| 2019-06-30 | -60.57% |
| 2019-03-31 | -50.64% |
| 2018-12-31 | -40.91% |
| 2018-09-30 | -65.77% |
| 2018-06-30 | -65.74% |
| 2018-03-31 | -71.42% |
| 2017-12-31 | -72.16% |
| 2017-09-30 | -83.16% |
| 2017-06-30 | -85.75% |
| 2017-03-31 | -75.92% |
| 2016-12-31 | -74.10% |
| 2016-09-30 | -60.16% |
| 2016-06-30 | -52.50% |
| 2016-03-31 | -69.50% |
| 2015-12-31 | -56.53% |
| 2015-09-30 | -15.47% |
| 2015-06-30 | -10.67% |
| 2015-03-31 | -5.42% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | -59.18% |
| 2014-06-30 | -44.66% |
| 2014-03-31 | -36.55% |
| 2013-12-31 | -69.75% |
